You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Med., 23 November 2022

Sec. Intensive Care Medicine and Anesthesiology

Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.1094735

Corrigendum: Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study

  • 1. Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany

  • 2. Institute for Clinical Epidemiology and Applied Biostatistics (IKEaB), Eberhard-Karls-University Tübingen, Tübingen, Germany

  • 3. Department of Thoracic and Cardiovascular Surgery, University Hospital Tübingen, Tübingen, Germany

Article metrics

View details

1,6k

Views

648

Downloads

In the published article, there was an error. The dosing of the continuous infusion of methylene blue is incorrect. Currently the text states “continuous infusion with 0.25 mg/kg/min” this should be changed to “continuous infusion with 0.25 mg/kg/h”.

A correction has been made to Methods, Methylene blue therapy, second paragraph. This sentence previously stated:

“Three different dosing strategies have been used in our institution in the past: bolus injection alone, continuous infusion without bolus, injection, or bolus injection followed by continuous infusion (bolus 2 mg/kg; continuous infusion with 0.25 mg/kg/min).”

The corrected sentence appears below:

“Three different dosing strategies have been used in our institution in the past: bolus injection alone, continuous infusion without bolus, injection, or bolus injection followed by continuous infusion (bolus 2 mg/kg; continuous infusion with 0.25 mg/kg/h).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

shock, methylene blue, critical care, retrospective study, clinical trial

Citation

Sari-Yavuz S, Heck-Swain K-L, Keller M, Magunia H, Feng Y-S, Haeberle HA, Wied P, Schlensak C, Rosenberger P and Koeppen M (2022) Corrigendum: Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study. Front. Med. 9:1094735. doi: 10.3389/fmed.2022.1094735

Received

10 November 2022

Accepted

14 November 2022

Published

23 November 2022

Volume

9 - 2022

Edited and reviewed by

Pavel Michalek, General University Hospital in Prague, Czechia

Updates

Copyright

*Correspondence: Michael Koeppen

This article was submitted to Intensive Care Medicine and Anesthesiology, a section of the journal Frontiers in Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics